Thomas Smith
Stock Analyst at Leerink Partners
(4.98)
# 66
Out of 4,634 analysts
685
Total ratings
56.9%
Success rate
51.3%
Average return
Main Sectors:
Stocks Rated by Thomas Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KROS Keros Therapeutics | Maintained: Buy | $35 → $23 | $10.69 | +115.15% | 53 | Aug 4, 2026 | |
| ALT Altimmune | Maintained: Buy | $10 | $3.05 | +227.87% | 2 | Jul 28, 2026 | |
| ARGX argenx SE | Maintained: Buy | $780 → $1,065 | $866.11 | +22.96% | 36 | Jul 24, 2026 | |
| CLDX Celldex Therapeutics | Maintained: Buy | $70 | $42.97 | +62.90% | 41 | Jul 22, 2026 | |
| AVTX Avalo Therapeutics | Initiated Coverage: Buy | $38 | $19.77 | +92.21% | 1 | Jul 6, 2026 | |
| CLYM Climb Bio | Reiterated: Buy | n/a | $13.54 | - | 8 | Jun 12, 2026 | |
| XFOR X4 Pharmaceuticals | Initiated Coverage: Buy | $12 | $4.25 | +182.35% | 1 | Jun 2, 2026 | |
| IRON Disc Medicine | Reiterated: Buy | n/a | $78.28 | - | 27 | Jun 2, 2026 | |
| EQ Equillium | Upgraded: Buy | $6 | $2.19 | +173.97% | 34 | May 28, 2026 | |
| RNAC Cartesian Therapeutics | Reiterated: Buy | n/a | $8.76 | - | 17 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $27.53 | +16.24% | 13 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $106 | $105.33 | +0.64% | 1 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $23.06 | +116.83% | 39 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 → $50 | $39.89 | +25.34% | 37 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $52 | $14.07 | +269.58% | 2 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $36 | $15.00 | +140.00% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.15 | - | 20 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $4.75 | +152.63% | 1 | Jan 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $32 | $7.89 | +305.58% | 18 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 102.00 | kr 39.62 | +157.45% | 1 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 | $34.44 | +242.62% | 38 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.78 | - | 3 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $5.90 | +18.64% | 34 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $104 → $115 | $127.50 | -9.80% | 17 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $73 → $14 | $17.33 | -19.22% | 32 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $515.34 | - | 39 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $9.57 | +171.68% | 15 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.68 | +117.39% | 34 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $15.67 | n/a | 8 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $15.60 | n/a | 16 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $14.10 | n/a | 28 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $17.80 | n/a | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.93 | n/a | 25 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $1.04 | n/a | 9 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $33 | $108.59 | n/a | 5 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.28 | n/a | 1 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $2 | $29.54 | n/a | 16 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 5,189p | 119p | n/a | 1 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $21 | $8.69 | n/a | 1 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $6 | $2.07 | n/a | 1 | Sep 8, 2017 |
Keros Therapeutics
Aug 4, 2026
Maintained: Buy
Price Target: $35 → $23
Current: $10.69
Upside: +115.15%
Altimmune
Jul 28, 2026
Maintained: Buy
Price Target: $10
Current: $3.05
Upside: +227.87%
argenx SE
Jul 24, 2026
Maintained: Buy
Price Target: $780 → $1,065
Current: $866.11
Upside: +22.96%
Celldex Therapeutics
Jul 22, 2026
Maintained: Buy
Price Target: $70
Current: $42.97
Upside: +62.90%
Avalo Therapeutics
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $38
Current: $19.77
Upside: +92.21%
Climb Bio
Jun 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.54
Upside: -
X4 Pharmaceuticals
Jun 2, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $4.25
Upside: +182.35%
Disc Medicine
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $78.28
Upside: -
Equillium
May 28, 2026
Upgraded: Buy
Price Target: $6
Current: $2.19
Upside: +173.97%
Cartesian Therapeutics
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.76
Upside: -
May 15, 2026
Reiterated: Buy
Price Target: $32
Current: $27.53
Upside: +16.24%
Apr 13, 2026
Reiterated: Buy
Price Target: $106
Current: $105.33
Upside: +0.64%
Apr 6, 2026
Reiterated: Buy
Price Target: $50
Current: $23.06
Upside: +116.83%
Apr 2, 2026
Reiterated: Buy
Price Target: $52 → $50
Current: $39.89
Upside: +25.34%
Mar 6, 2026
Reiterated: Buy
Price Target: $42 → $52
Current: $14.07
Upside: +269.58%
Mar 3, 2026
Initiated Coverage: Buy
Price Target: $36
Current: $15.00
Upside: +140.00%
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.15
Upside: -
Jan 11, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $4.75
Upside: +152.63%
Dec 15, 2025
Reiterated: Buy
Price Target: $25 → $32
Current: $7.89
Upside: +305.58%
Nov 26, 2025
Initiated Coverage: Buy
Price Target: kr 102.00
Current: kr 39.62
Upside: +157.45%
Oct 23, 2025
Reiterated: Buy
Price Target: $118
Current: $34.44
Upside: +242.62%
Oct 21, 2025
Reiterated: Buy
Price Target: n/a
Current: $3.78
Upside: -
Oct 15, 2025
Reiterated: Buy
Price Target: $7
Current: $5.90
Upside: +18.64%
Oct 8, 2025
Reiterated: Buy
Price Target: $104 → $115
Current: $127.50
Upside: -9.80%
Oct 1, 2025
Maintained: Buy
Price Target: $73 → $14
Current: $17.33
Upside: -19.22%
Aug 19, 2025
Maintained: Buy
Price Target: n/a
Current: $515.34
Upside: -
Aug 18, 2025
Reiterated: Buy
Price Target: $26
Current: $9.57
Upside: +171.68%
Aug 15, 2025
Reiterated: Buy
Price Target: $8
Current: $3.68
Upside: +117.39%
Apr 16, 2025
Maintained: Hold
Price Target: n/a
Current: $15.67
Upside: n/a
Aug 28, 2024
Reiterated: Buy
Price Target: $58
Current: $15.60
Upside: n/a
Aug 8, 2024
Maintained: Hold
Price Target: $5
Current: $14.10
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: $6
Current: $17.80
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: $7
Current: $3.93
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: $46
Current: $1.04
Upside: n/a
Aug 7, 2024
Maintained: Hold
Price Target: $33
Current: $108.59
Upside: n/a
Mar 15, 2024
Maintained: Buy
Price Target: n/a
Current: $6.28
Upside: n/a
Aug 15, 2023
Downgraded: Hold
Price Target: $13 → $2
Current: $29.54
Upside: n/a
Aug 8, 2022
Maintained: Buy
Price Target: 5,189p
Current: 119p
Upside: n/a
Jan 17, 2019
Initiated Coverage: Hold
Price Target: $21
Current: $8.69
Upside: n/a
Sep 8, 2017
Initiated Coverage: Hold
Price Target: $6
Current: $2.07
Upside: n/a